Article Link: Ibrance (palbociclib) Receives FDA Regular Approval and Expanded Indication for First-Line HR+, HER2- Metastatic Breast Cancer �...

Article Link: Tagrisso (osimertinib) Receives FDA Full Approval Source: FDA New Drug Approvals

Article Link: FDA Approves Addition of Moderate to Severe Fingernail Psoriasis Data to AbbVie’s Humira (adalimumab) Prescribing Information ...

Article Link: FDA Approves Expanded Indication for Qudexy XR (topiramate) Extended-Release Capsules to Include Prophylaxis of Migraine Headache in Adu...

Article Link: FDA Approves Ocrevus (ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple Sclerosis Source: ...

Article Link: FDA Approves Dupixent (dupilumab) for Eczema Source: FDA New Drug Approvals

Article Link: Tesaro Announces FDA Approval of Zejula (niraparib) for Women with Recurrent Ovarian Cancer Source: FDA New D...

Article Link: FDA Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma Source: FDA New Drug Approvals

Article Link: FDA Approves Symproic (naldemedine) for the Treatment of Opioid-Induced Constipation Source: FDA New Drug App...

Article Link: FDA Approves Xadago (safinamide) as an Add-On Treatment for Patients with Parkinson’s Disease Source: FDA New...